BioCryst Pharmaceuticals
BCRX
#4608
Rank
A$2.52 B
Marketcap
$12.22
Share price
2.39%
Change (1 day)
4.03%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

Volume in USD (price x number of shares), data since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$2.38 M-8.87%
2023A$2.61 M-87.57%
2022A$21.02 M-74.17%
2021A$81.38 M69.16%
2020A$48.11 M440.33%
2019A$8.9 M100.99%
2018A$4.43 M-68.51%
2017A$14.06 M277.58%
2016A$3.72 M-78.39%
2015A$17.23 M10.36%
2014A$15.62 M95.45%
2013A$7.99 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
A$8.53 MA$63.57 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$22.99 MA$39.93 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.36 MA$2.48 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$45.2 MA$0.29 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$35.43 MA$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.23 MA$5.83 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$22.53 MA$43.31 M๐Ÿ‡ฌ๐Ÿ‡ง UK
A$1.82 MA$8.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.04 MA$5.24 M๐Ÿ‡บ๐Ÿ‡ธ USA